Publicação

World delirium awareness and quality survey in 2023 - A worldwide point prevalence study

Ver documento

Detalhes bibliográficos
Resumo:Background: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia. Objectives: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities. Design: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023. Participants: Clinicians or researchers with access to clinical data. Main Outcome and Measure: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed. Results: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%). Conclusion and Relevance: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.
Autores principais:Lindroth, Heidi
Outros Autores:Liu, Keibun; Szalacha, Laura; Ashkenazy, Shelly; Bellelli, Giuseppe; Van Den Boogaard, Mark; Caplan, Gideon; Chung, Chi Ryang; Elhadi, Muhammed; Gurjar, Mohan; Heras-La-Calle, Gabriel; Hoffman, Magdalena; Jeitziner, Marie Madlen; Krewulak, Karla; Mailhot, Tanja; Morandi, Alessandro; Nawa, Ricardo Kenji; Oh, Esther S.; Collet, Marie Oxenboell; Paulino, Maria Carolina; Von Haken, Rebecca; Nydahl, Peter; Abdalgany, Ahmed Gaber Ahmed; Abdelmohsen, Sarah Magdy; Aburaas, Amjad; Aggar, Christina; Albakosh, Bashir Abobaker; Alhamdan, Hamza Ismail Ahmad; Aljbali, Akram Waled Rajab M.; Alkandari, Farah; Alkaseek, Akram; Anders, Daniel; Anderson, Marsali; Avelino, Thiago; Bail, Kasia Siobhan; Bakri, Ashraf; Baroum, Alaa Mohamed Ali; Benbenishty, Julie; Blackwood, Bronagh; Brendt-Müller, Jennifer; Brobeil, Angelika; Burke, Richard; Byrnes, Tru; Cacciatore, Stefano; Cahill, Maria; Canelas, Maria Ana; Carroll, Ida; Conley, Amy; Costello, Maria; Cotton, Shannon
Assunto:cross-sectional studies delivery of health care global delirium prevalence older people standard of practice Ageing Geriatrics and Gerontology
Ano:2024
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Universidade Nova de Lisboa
Idioma:inglês
Origem:Repositório Institucional da UNL
Descrição
Resumo:Background: Delirium, an acute brain dysfunction, is proposed to be highly prevalent in clinical care and shown to significantly increase the risk of mortality and dementia. Objectives: To report on the global prevalence of clinically documented delirium and delirium-related clinical practices in wards caring for paediatric and adult patients in healthcare facilities. Design: A prospective, cross-sectional, 39-question survey completed on World Delirium Awareness Day, 15 March 2023. Participants: Clinicians or researchers with access to clinical data. Main Outcome and Measure: The primary outcome was the prevalence of clinically documented delirium at 8:00 a.m. (4 h) and 8:00 p.m. (±4 h). Secondary outcomes included delirium-related care practices and barriers to use. Descriptive statistics were calculated and multilevel modelling was completed. Results: 1664 wards submitted surveys from 44 countries, reporting on delirium assessments at 8:00 a.m. (n = 36 048) and 8:00 p.m. (n = 32 867); 61% reported use of validated delirium assessment tools. At 8:00 a.m., 18% (n = 2788/15 458) and at 8:00 p.m., 17.7% (n = 2454/13 860) were delirium positive. Top prevention measures were pain management (86.7%), mobilisation (81.4%) and adequate fluids (80.4%). Frequently reported pharmacologic interventions were benzodiazepines (52.7%) and haloperidol (46.2%). Top barriers included the shortage of staff (54.3%), lack of time to educate staff (48.6%) and missing knowledge about delirium (38%). Conclusion and Relevance: In this study, approximately one out of five patients were reported as delirious. The reported high use of benzodiazepines needs further evaluation as it is not aligned with best-practice recommendations. Findings provide a benchmark for future quality improvement projects and research.